Bristol-Myers Squibb Co. (NYSE:BMY)

The financial performance across the analyzed period is characterized by a steady erosion of gross profitability and a severe, temporary contraction in operational and net earnings during the 2024 calendar year, followed by a robust recovery throughout 2025 and early 2026.

Gross Profit Margin

A consistent downward trend is observed, with the margin declining from 79.62% in March 2022 to a low of 69.50% in September 2025. This suggests a gradual increase in the cost of goods sold relative to revenue or a shift in product mix toward lower-margin offerings.

Operating and Net Profit Margins

Both metrics exhibited stability and modest growth from early 2022 through late 2023, with the net profit margin peaking at 18.44% in September 2023. However, a sharp reversal occurred in March 2024, where both margins plummeted into negative territory. The operating profit margin reached a trough of -15.50% in December 2024, while the net profit margin fell to -18.53% in the same period. A significant recovery followed in 2025, with the operating margin eventually surpassing pre-crisis levels to reach 20.55% by March 2026.

Return on Equity (ROE)

The ROE displayed extreme volatility, mirroring the trends seen in net profitability. After rising to a peak of 28.57% in September 2023, the ratio collapsed to -37.28% in March 2024 and reached a nadir of -54.78% in December 2024. The recovery was rapid, with ROE rebounding to 31.16% by March 2025 and peaking at 38.19% in December 2025, indicating a strong restoration of shareholder value generation.

Return on Assets (ROA)

ROA followed a trajectory similar to ROE but with less amplification. The ratio climbed to 9.08% in September 2023 before falling to a low of -9.66% in December 2024. By March 2026, the ROA returned to a positive state of 8.41%, reflecting a restoration of asset utilization efficiency.

In summary, the data indicates a period of significant financial distress during 2024 that severely impacted all profitability and return metrics. While gross margins have not recovered to their 2022 levels, the operational and bottom-line recovery in 2025 suggests an effective correction of the factors that caused the 2024 downturn.

An analysis of the gross profit margin from March 2022 through March 2026 reveals a consistent and sustained contraction in profitability. The margin declined from a peak of 79.62% to 70.46% over the analyzed timeframe, indicating a systemic increase in the cost of goods sold relative to total revenues.

Steady Margin Erosion (2022–2024)

During the initial period from March 2022 to September 2024, the gross profit margin experienced a gradual and near-linear decline. The ratio decreased incrementally from 79.62% to 74.91%, reflecting a steady reduction in the efficiency of production costs or a shift in the product mix toward lower-margin offerings.

Accelerated Contraction (Q4 2024)

A significant acceleration in margin compression occurred in the fourth quarter of 2024. The gross profit margin dropped sharply from 74.91% in September to 71.08% in December, marking one of the most abrupt declines in the observed period.

Lower-Level Stabilization (2025–2026)

Following the sharp decline in late 2024, the margin entered a period of stabilization at a lower baseline. Profitability fluctuated within a narrow corridor between 69.50% and 71.08%. The lowest recorded margin occurred in September 2025 at 69.50%, followed by a marginal recovery to 71.08% in December 2025 and a slight dip to 70.46% by March 2026.

While revenues remained relatively resilient, fluctuating between 10.9 billion and 12.5 billion US dollars, the gross margin in absolute terms demonstrated volatility. The divergence between stable revenue streams and a declining percentage margin suggests that cost pressures have outpaced pricing adjustments or revenue growth over the four-year period.

The operating profit margin demonstrates a highly volatile trajectory characterized by a period of stability, a severe contraction into negative territory, and a robust recovery ending in margin expansion. While revenues remained relatively consistent, oscillating between approximately 10.9 billion and 12.5 billion US dollars, the operating profit margin experienced significant swings driven by fluctuations in operating income.

Baseline Stability (March 2022 – December 2023)

During this period, the operating profit margin remained positive and relatively stable, fluctuating within a range of 16.18% to 19.04%. A peak of 19.04% was reached in September 2022, followed by a gradual downward trend that concluded the 2023 calendar year at 16.18%.

Period of Severe Contraction (March 2024 – December 2024)

A sharp reversal occurred in early 2024, with the margin shifting to negative values. This contraction coincided with a substantial operating loss of 11.4 billion US dollars in the first quarter of 2024. Throughout the remainder of the year, the margin remained depressed, reaching its lowest point of -15.50% in December 2024.

Recovery and Margin Expansion (March 2025 – March 2026)

A significant recovery is evident starting in March 2025, as the margin returned to positive territory at 15.24%. This upward momentum continued throughout 2025, peaking at 20.75% in December 2025. The period concluded in March 2026 with a margin of 20.55%, representing a higher baseline of profitability than observed in the pre-2024 period.

The net profit margin exhibits a period of steady growth followed by a severe contraction and a subsequent recovery phase. Between March 2022 and September 2023, the margin demonstrated a consistent upward trajectory, peaking at 18.44% before experiencing a slight moderation toward the end of 2023.

Initial Profitability Expansion (March 2022 – December 2023)

A period of margin expansion is observed, where the net profit margin rose from 13.31% to a high of 18.44% in September 2023. This growth indicates an increasing ability to convert revenue into actual profit during this interval.

Severe Margin Contraction (March 2024 – December 2024)

A sharp reversal occurred starting in March 2024, characterized by a transition into negative profitability. The margin plummeted to -13.50% in the first quarter of 2024 and continued to deteriorate throughout the year, reaching a nadir of -18.53% by December 31, 2024. This period represents a significant volatility event where losses outweighed revenues.

Recovery and Stabilization (March 2025 – March 2026)

A recovery trend began in March 2025, as the net profit margin returned to positive territory at 11.38%. A gradual and steady climb followed, with the margin increasing to 15.01% by March 31, 2026. This indicates a restoration of profitability, although the levels remain slightly below the peak observed in 2023.

Overall, the analysis reveals a cyclical pattern of stability, extreme volatility, and recovery. While revenues remained relatively stable throughout the entire period, fluctuations in net earnings drove the dramatic swings in the net profit margin.

The return on equity (ROE) exhibits a trajectory characterized by initial steady growth, a period of severe volatility and negative returns, and a subsequent strong recovery. The performance is closely linked to significant fluctuations in net earnings and a substantial reduction in total shareholders' equity during the 2024 fiscal year.

Initial Growth Phase (2022 – 2023)

Between March 2022 and December 2023, ROE demonstrated a consistent upward trend, rising from 19.79% to 27.27%. This growth was supported by steady increases in quarterly net earnings, which grew from 1,278 million USD to a peak of 2,262 million USD in March 2023. During this period, shareholders' equity remained relatively stable, fluctuating within a narrow range between 28,998 million USD and 32,671 million USD.

Performance Contraction and Volatility (2024)

A sharp reversal occurred in the first quarter of 2024, marked by a substantial net loss of 11,911 million USD. This resulted in a precipitous drop in ROE to -37.28%. This period also saw a significant contraction in shareholders' equity, which fell from 29,430 million USD in December 2023 to 16,490 million USD by March 2024. Despite a return to positive quarterly earnings for the remainder of the year, the ROE continued to decline further, reaching a low of -54.78% by December 31, 2024, suggesting the lingering impact of the previous massive loss on annualized or trailing performance metrics.

Recovery and Stabilization (2025 – 2026)

Beginning in March 2025, a robust recovery in ROE is observed, with the ratio rebounding to 31.16% and eventually reaching 36.25% by March 2026. This recovery was driven by a return to consistent positive net earnings, peaking at 2,677 million USD in the final analyzed quarter. The ROE levels in this phase exceeded the pre-2024 levels, a trend partially amplified by a lower equity base, which stabilized and grew modestly from 17,389 million USD in December 2024 to 20,068 million USD by March 2026.

The analysis of the return on assets (ROA) from March 2022 through March 2026 reveals a trajectory characterized by early growth, a period of severe volatility, and a subsequent recovery toward historical norms.

Initial Growth Trend (March 2022 – September 2023)

A steady improvement in asset utilization efficiency was observed during the first several quarters. ROA climbed from 6.07% in March 2022 to a peak of 9.08% in September 2023. This expansion was supported by a simultaneous increase in net earnings and a gradual reduction in the total asset base, which decreased from $103,034 million to $91,263 million during this timeframe.

Period of Significant Decline (March 2024 – December 2024)

A sharp reversal in profitability occurred in March 2024, marked by a substantial net loss of $11,911 million, which drove the ROA to -6.21%. Despite a return to positive net earnings in the following quarters of 2024, the ROA continued to deteriorate, reaching a low of -9.66% by December 2024. This period represents a significant anomaly in the overall profitability trend.

Recovery and Stabilization (March 2025 – March 2026)

A recovery phase began in March 2025, as ROA returned to positive territory at 5.86%. An upward trend resumed thereafter, with the ratio reaching 8.41% by March 2026. This rebound was facilitated by a return to higher net earnings and a further contraction of total assets, which reached a period low of $86,476 million.

Asset Base Correlation

A consistent long-term reduction in total assets is evident, falling from over $103 billion in early 2022 to approximately $86.5 billion by March 2026. The decreasing denominator in the ROA calculation suggests that the company became more sensitive to fluctuations in net earnings, thereby magnifying the impact of both the 2024 losses and the 2025-2026 recovery.